Provided by Tiger Fintech (Singapore) Pte. Ltd.

Achieve Life Sciences, Inc.

4.20
+1.1236.36%
Post-market: 4.07-0.1293-3.08%19:59 EDT
Volume:15.97M
Turnover:65.53M
Market Cap:214.64M
PE:-2.88
High:4.44
Open:3.97
Low:3.71
Close:3.08
52wk High:5.31
52wk Low:1.84
Shares:51.10M
Float Shares:44.42M
Volume Ratio:10.92
T/O Rate:35.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4583
EPS(LYR):-1.2418
ROE:-120.11%
ROA:-50.63%
PB:5.15
PE(LYR):-3.38

Loading ...

Achieve Life Sciences (ACHV) Gets a Buy from Raymond James

TIPRANKS
·
Yesterday

BUZZ-U.S. STOCKS ON THE MOVE- SLB NV, Bank OZK, Gilead Sciences

Reuters
·
Yesterday

FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times

Benzinga_recent_news
·
Oct 17

Shares of Some US Drug Developers up After FDA Announces Recipients of National Priority Vouchers

THOMSON REUTERS
·
Oct 17

Revolution Medicines up 6%, Achieve Life Sciences up 22.1%, Disc Medicine up 19.2%

THOMSON REUTERS
·
Oct 17

BRIEF-Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher For Cytisinicline For Treatment Of Nicotine Dependence For E-Cigarette Or Vaping Cessation

Reuters
·
Oct 17

Achieve Life Sciences Inc - FDA-Assessment Time Reduced to 1-2 Months for Cytisinicline

THOMSON REUTERS
·
Oct 17

Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-Cigarette or Vaping Cessation

THOMSON REUTERS
·
Oct 17

US FDA: Products Nominated for National Priority Vouchers Include Teplizumab for Type I Diabetes, Cytisinicline for Nicotine Vaping Addiction

THOMSON REUTERS
·
Oct 17

FDA: Anticipates Announcing Another Group of Commissioner’s National Priority Voucher Recipients in the Coming Months

THOMSON REUTERS
·
Oct 17

FDA: Products Nominated for National Priority Vouchers Include Bitopertin for Porphyria, Ketamine for Domestic Manufacturing of a General Anesthetic

THOMSON REUTERS
·
Oct 17

US FDA Awards First-Ever National Priority Vouchers to Nine Sponsors

THOMSON REUTERS
·
Oct 17

Recent uptick might appease Achieve Life Sciences, Inc. (NASDAQ:ACHV) institutional owners after losing 33% over the past year

Simply Wall St.
·
Oct 09

Achieve Life Sciences Announces Resignation of President and Chief Medical Officer Dr. Cindy Jacobs, Appoints Her as Consultant Pending FDA Approval

Reuters
·
Oct 08

BRIEF-Achieve Promotes Jason Yee To Chief Financial Officer

Reuters
·
Sep 29

Achieve Promotes Jason Yee to Chief Financial Officer

THOMSON REUTERS
·
Sep 29

CFO Mark K. Oki Reports Disposal of Common Shares in Achieve Life Sciences Inc

Reuters
·
Sep 24

Lake Street Remains a Buy on Achieve Life Sciences (ACHV)

TIPRANKS
·
Sep 23

Achieve Life Sciences (ACHV) Receives a Buy from JonesTrading

TIPRANKS
·
Sep 23

Achieve Life Sciences announces publication of data on cytisinicline

TIPRANKS
·
Sep 22